Characteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclasses
about
Cross-Reactivity, Epitope Spreading, and De Novo Immune Stimulation Are Possible Mechanisms of Cross-Protection of Nonvaccine Human Papillomavirus (HPV) Types in Recipients of HPV Therapeutic VaccinesImmunogenicity of a trivalent human papillomavirus L1 DNA-encapsidated, non-replicable baculovirus nanovaccine.Impact of smoking on the quantity and quality of antibodies induced by human papillomavirus type 16 and 18 AS04-adjuvanted virus-like-particle vaccine - a pilot studyAlternative dosage schedules with HPV virus-like particle vaccines.Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteinsSkin and mucosal human papillomavirus seroprevalence in persons with Fanconi Anemia.A Bivariate Mixture Model for Natural Antibody Levels to Human Papillomavirus Types 16 and 18: Baseline Estimates for Monitoring the Herd Effects of ImmunizationA DNA vaccine encoding mutated HPV58 mE6E7-Fc-GPI fusion antigen and GM-CSF and B7.1.A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected SubjectsThe DE and FG loops of the HPV major capsid protein contribute to the epitopes of vaccine-induced cross-neutralising antibodies.Cross-neutralizing antibodies elicited by the Cervarix® human papillomavirus vaccine display a range of Alpha-9 inter-type specificities.Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes.Bias Due to Correlation Between Times-at-Risk for Infection in Epidemiologic Studies Measuring Biological Interactions Between Sexually Transmitted Infections: A Case Study Using Human Papillomavirus Type Interactions.Tumour virus vaccines: hepatitis B virus and human papillomavirus.Carcinogenic human papillomavirus infection.
P2860
Q28085724-E3E7CEFB-D941-4744-8024-0EF1F0B710EEQ31159398-398047BD-0FAE-475C-BC82-C12B1BECA30DQ33929216-C124FBF2-B830-4412-89CD-CAE9C35E8014Q34102466-4DC99C15-087D-4BC4-9F96-FCABDF3A4F4FQ34492140-D8936D82-294A-4C08-973C-3825A408437CQ35221196-0B92AB5C-95FE-46B4-AEE4-48E42FFE5993Q36106799-93F25C0D-461E-4B9E-A8F8-1B8660C4E455Q36244253-2578CE09-0A0C-45CD-B71A-A0FC6795F725Q37221868-93E2B15F-3900-499E-87CB-57517487BD33Q37526148-E1722583-3481-4556-862D-FDE7E83E1E0FQ37671423-A11D2966-62A9-409D-A72B-A397C6B85873Q38808706-885A2CC7-A58C-4873-BD09-3B82FDF3C737Q39122093-0BB3B774-6CF0-41E6-9956-BB760E782DE8Q40046649-2A1F4560-26A1-444A-8ACE-47A77B319558Q44863515-F3FE0346-9DD2-40F1-A123-38E497A24FF6
P2860
Characteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclasses
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Characteristics of HPV-specifi ...... ty, avidity and IgG subclasses
@ast
Characteristics of HPV-specifi ...... ty, avidity and IgG subclasses
@en
Characteristics of HPV-specifi ...... ty, avidity and IgG subclasses
@nl
type
label
Characteristics of HPV-specifi ...... ty, avidity and IgG subclasses
@ast
Characteristics of HPV-specifi ...... ty, avidity and IgG subclasses
@en
Characteristics of HPV-specifi ...... ty, avidity and IgG subclasses
@nl
prefLabel
Characteristics of HPV-specifi ...... ty, avidity and IgG subclasses
@ast
Characteristics of HPV-specifi ...... ty, avidity and IgG subclasses
@en
Characteristics of HPV-specifi ...... ty, avidity and IgG subclasses
@nl
P2093
P2860
P1433
P1476
Characteristics of HPV-specifi ...... ty, avidity and IgG subclasses
@en
P2093
Chris J L M Meijer
Fiona R M van der Klis
Guy A M Berbers
Madelief Mollers
Mirte Scherpenisse
Rutger M Schepp
P2860
P304
P356
10.1371/JOURNAL.PONE.0074797
P407
P577
2013-09-18T00:00:00Z